108 related articles for article (PubMed ID: 8678909)
1. The 2,2'-bipyridyl-6-carbothioamide copper (II) complex differs from the iron (II) complex in its biochemical effects in tumor cells, suggesting possible differences in the mechanism leading to cytotoxicity.
Nocentini G; Barzi A
Biochem Pharmacol; 1996 Jul; 52(1):65-71. PubMed ID: 8678909
[TBL] [Abstract][Full Text] [Related]
2. 2,2'-Bipyridyl-6-carbothioamide and its ferrous complex: their in vitro antitumoral activity related to the inhibition of ribonucleotide reductase R2 subunit.
Nocentini G; Federici F; Franchetti P; Barzi A
Cancer Res; 1993 Jan; 53(1):19-26. PubMed ID: 8416745
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of 2,2'-bipyridyl-6-carbothioamide: a ribonucleotide reductase inhibitor.
Nocentini G; Barzi A
Gen Pharmacol; 1997 Nov; 29(5):701-6. PubMed ID: 9347313
[TBL] [Abstract][Full Text] [Related]
4. Isolation of two cellular lines resistant to ribonucleotide reductase inhibitors to investigate the inhibitory activity of 2,2'-bipyridyl-6-carbothioamide.
Nocentini G; Federici F; Armellini R; Franchetti P; Barzi A
Anticancer Drugs; 1990 Dec; 1(2):171-7. PubMed ID: 2131050
[TBL] [Abstract][Full Text] [Related]
5. Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).
Heffeter P; Popovic-Bijelic A; Saiko P; Dornetshuber R; Jungwirth U; Voevodskaya N; Biglino D; Jakupec MA; Elbling L; Micksche M; Szekeres T; Keppler BK; Gräslund A; Berger W
Curr Cancer Drug Targets; 2009 Aug; 9(5):595-607. PubMed ID: 19508176
[TBL] [Abstract][Full Text] [Related]
6. Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase.
Nocentini G; Barzi A; Franchetti P
Cancer Chemother Pharmacol; 1990; 26(5):345-51. PubMed ID: 2208576
[TBL] [Abstract][Full Text] [Related]
7. New Iminodiacetate-Thiosemicarbazone Hybrids and Their Copper(II) Complexes Are Potential Ribonucleotide Reductase R2 Inhibitors with High Antiproliferative Activity.
Zaltariov MF; Hammerstad M; Arabshahi HJ; Jovanović K; Richter KW; Cazacu M; Shova S; Balan M; Andersen NH; Radulović S; Reynisson J; Andersson KK; Arion VB
Inorg Chem; 2017 Mar; 56(6):3532-3549. PubMed ID: 28252952
[TBL] [Abstract][Full Text] [Related]
8. Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase.
Nocentini G; Barzi A
Pharmacol Res; 1990; 22 Suppl 1():39-40. PubMed ID: 2284243
[No Abstract] [Full Text] [Related]
9. 2,2'-Bipyridyl-6-carbothioamide derivatives as potential antitumor agents.
Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Filippeschi S
Farmaco Sci; 1986 May; 41(5):346-54. PubMed ID: 3720944
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of P388 murine leukemia cells to hydroxyurea cytotoxicity by hydrophobic iron-chelating agents.
Satyamoorthy K; Chitnis M; Basrur V
Anticancer Res; 1986; 6(2):329-33. PubMed ID: 3518597
[TBL] [Abstract][Full Text] [Related]
11. Combined modality treatment with ternary Cu(II) complexes and X rays.
O'Hara JA; Douple EB; Abrams MJ; Giandomenico CM; Bradley FC; McElligott MA; Caruso FS
Int J Radiat Oncol Biol Phys; 1992; 22(3):607-12. PubMed ID: 1735700
[TBL] [Abstract][Full Text] [Related]
12. Evidence that dopachrome tautomerase is a ferrous iron-binding glycoprotein.
Chakraborty AK; Orlow SJ; Pawelek JM
FEBS Lett; 1992 May; 302(2):126-8. PubMed ID: 1633843
[TBL] [Abstract][Full Text] [Related]
13. Pyrazolone incorporating bipyridyl metallointercalators as effective DNA, protein and lung cancer targets: Synthesis, characterization and in vitro biocidal evaluation.
Vyas KM; Devkar RV; Prajapati A; Jadeja RN
Chem Biol Interact; 2015 Oct; 240():250-66. PubMed ID: 26341650
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of copper complexes of some 2,2'-bipyridyl analogs on Paracoccus denitrificans.
Smit H; van der Goot H; Nauta WT; Pijper PJ; Balt S; de Bolster MW; Stouthamer AH; Verheul H; Vis RD
Antimicrob Agents Chemother; 1980 Aug; 18(2):249-56. PubMed ID: 6778379
[TBL] [Abstract][Full Text] [Related]
15. The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds.
Côrte-Real L; Robalo MP; Marques F; Nogueira G; Avecilla F; Silva TJ; Santos FC; Tomaz AI; Garcia MH; Valente A
J Inorg Biochem; 2015 Sep; 150():148-59. PubMed ID: 26150132
[TBL] [Abstract][Full Text] [Related]
16. DNA strand scission by the nephrotoxin [2,2'-bipyridine]-3,3',4,4'-tetrol-1,1'-dioxide and related compounds in the presence of iron.
Cantin-Esnault D; Oubrahim H; Richard JM
Free Radic Res; 2000 Aug; 33(2):129-37. PubMed ID: 10885620
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling reveals that collismycin A is an iron chelator.
Kawatani M; Muroi M; Wada A; Inoue G; Futamura Y; Aono H; Shimizu K; Shimizu T; Igarashi Y; Takahashi-Ando N; Osada H
Sci Rep; 2016 Dec; 6():38385. PubMed ID: 27922079
[TBL] [Abstract][Full Text] [Related]
18. Intracellular chelation of iron by bipyridyl inhibits DNA virus replication: ribonucleotide reductase maturation as a probe of intracellular iron pools.
Romeo AM; Christen L; Niles EG; Kosman DJ
J Biol Chem; 2001 Jun; 276(26):24301-8. PubMed ID: 11301321
[TBL] [Abstract][Full Text] [Related]
19. Growth, ribonucleotide reductase and metals in murine leukemic lymphocytes.
Oblender M; Carpentieri U
J Cancer Res Clin Oncol; 1991; 117(5):444-8. PubMed ID: 1890140
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structural characterization of ternary Cu (II) complexes of glycine with 2,2'-bipyridine and 2,2'-dipyridylamine. The DNA-binding studies and biological activity.
Mohamed MS; Shoukry AA; Ali AG
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Feb; 86():562-70. PubMed ID: 22153742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
